Macrolactone derivatives

US8268775B2 · kind B2 · utility

Assignee

• Sanofi · FR

Inventors

• Holger Hoffmann · Frankfurt am Main, DE
• Christine Klemke-Jahn · Frankfurt am Main, DE
• Dietmar Schummer · Langen, DE
• Herbert Kogler · Königstein, DE

Key dates

• Filing date: Dec 17, 2009
• Grant date: Sep 18, 2012
• Expiry date: Dec 17, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12R2001/01
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The disclosure relates to compounds of the formula (I):wherein R1, R2, R3, and R4 are as defined in the disclosure, or a pharmaceutically acceptable salt thereof; which is formed by the microorganism ST 201196 (DSM 18870); the use thereof for the treatment and/or prophylaxis of fungal disorders; medicaments containing a compound of formula (I); processes for production thereof; and the microorganism ST 201196 (DSM 18870).